Description
Key Benefits
-
Designed for localised periorbital irregularities after HA injections
-
Contains a multi-enzyme complex including hyaluronidase, lipase and protease
-
Topical professional application avoids direct injection of the product
-
Includes botanical ingredients selected for skin comfort
Clinical Benefits
-
Targeted HA Management: Hyaluronidase enzymatically degrades hyaluronic acid. In Topilase, it is incorporated into a topical system intended by Softfil for selected superficial periorbital irregularities.
-
Procedure-Specific Positioning: The product is positioned as a non-injectable care option for appropriate cases; it should not be considered equivalent to injected hyaluronidase for urgent or significant filler complications.
Product Profile
Topical delivery, depth of filler placement and the nature of the irregularity all influence whether a topical enzyme product can be clinically relevant. Vascular occlusion, visual symptoms, severe pain or other acute filler complications require immediate medical assessment and should not be managed with topical Topilase alone.
Use should follow SoftFil’s current professional instructions and patient-selection criteria.
Reviews
There are no reviews yet.